WHO Updates 2026–2027 Influenza Vaccine Formula; Nigeria Urged To Strengthen Surveillance, Preparedness

GENEVA, ISTANBUL – The World Health Organization has updated the viral composition for the 2026–2027 northern hemisphere influenza vaccines, following a four-day global consultation in Geneva and Istanbul.

The recommendations respond to evolving influenza strains, particularly a fast-spreading A(H3N2) variant that triggered early outbreaks across multiple regions.

Although Nigeria lies within the tropical belt, public health experts say the development directly concerns national disease surveillance and seasonal preparedness strategies.

Health officials in Abuja confirmed that global influenza updates guide laboratory tracking systems, vaccine procurement decisions, and risk communication planning across Nigeria.

WHO Director-General Tedros Adhanom Ghebreyesus said the world remains interconnected through rapidly evolving respiratory viruses.

“Season after season, constantly evolving influenza viruses circulate globally, showing us how connected our world is,” Tedros stated during the announcement.

He added that shared risks require coordinated international action anchored on surveillance data generated year-round by expert laboratories.

Emerging A(H3N2) Variant Raises Global Alarm

In August 2025, a notably different A(H3N2) variant classified as J.2.4.1, also called subclade K, emerged and spread rapidly worldwide.

WHO reported that the variant contributed to earlier influenza seasons in several countries, with unusually high transmission levels recorded.

Influenza A viruses dominated reported cases globally, while other A(H1N1) and B/Victoria lineage strains circulated at lower levels.

No confirmed B/Yamagata lineage viruses have been detected globally since March 2020, according to surveillance findings.

Public health researchers in Nigeria say such global shifts influence local influenza epidemiology, especially during harmattan and rainy seasons.

A senior epidemiologist at the Nigeria Centre for Disease Control and Prevention explained that viral mutations affect vaccine effectiveness projections.

He said Nigeria relies on international genomic data to anticipate strain importation through international travel and migration patterns.

Although influenza vaccination coverage remains low nationally, experts insist preparedness remains essential to prevent severe outbreaks.

• Anambra Native Doctor Bags 11 Months Jail Term
• Dangote Opens Refinery Shares to Ordinary Nigerians, Sets June, July Window
• Odigie-Oyegun Expresses Doubt Over Police Ability To Arrest Edo Gun Attack Suspects
• Pope Leo XIV to Make Historic Visit to Africa in April
• NUC Issues New Guidelines Regulating Award, Use of Honorary Doctorate Degrees

Vaccine Composition for 2026–2027 Season

For egg-based vaccines, WHO recommended inclusion of A/Missouri/11/2025 (H1N1)pdm09-like, A/Darwin/1454/2025 (H3N2)-like, and B/Tokyo/EIS13-175/2025-like viruses.

For cell culture or recombinant platforms, experts recommended A/Missouri/11/2025 (H1N1)pdm09-like, A/Darwin/1415/2025 (H3N2)-like, and B/Pennsylvania/14/2025-like viruses.

WHO officials explained that vaccine compositions require periodic updates because influenza viruses constantly change genetically and antigenically.

The recommendations guide pharmaceutical manufacturers and national regulatory agencies in producing closely matched seasonal vaccines.

A public health physician at the University of Abuja Teaching Hospital noted that Nigeria imports most influenza vaccines through private supply chains.

He stressed that regulatory alignment with WHO guidance ensures imported vaccines remain effective against circulating strains.

Zoonotic Influenza and Nigeria’s Risk Landscape

Experts also reviewed zoonotic influenza viruses circulating in animals, particularly those infecting humans through animal exposure.

Since September 23, 2025, WHO documented 25 human infections with zoonotic influenza across six countries.

Most infected individuals reported direct contact with contaminated environments or infected poultry, without confirmed human-to-human transmission.

At the consultation, experts recommended developing a new candidate vaccine virus targeting A(H9N2), a strain commonly linked to poultry exposure.

Nigeria’s poultry sector remains expansive, employing millions and sustaining food security across rural communities.

Veterinary authorities previously recorded avian influenza outbreaks in parts of Nigeria, heightening concerns about cross-species transmission risks.

A livestock epidemiologist in Ibadan warned that informal live-bird markets increase exposure to zoonotic pathogens.

He explained that integrated animal-human surveillance remains critical to detecting early warning signals of pandemic-prone strains.

Surveillance Systems and National Preparedness

Global influenza monitoring operates under WHO’s Global Influenza Surveillance and Response System, established in 1952.

The network coordinates laboratories and essential regulatory centres that analyze virus samples from participating countries.

Nigeria participates in international disease reporting platforms through its national influenza sentinel surveillance sites.

Health ministry officials say strengthening laboratory sequencing capacity remains central to preparedness against respiratory epidemics.

Seasonal influenza causes an estimated one billion infections annually, including up to five million severe cases worldwide.

WHO estimates between 290,000 and 650,000 respiratory deaths occur globally each year due to influenza complications.

Nigerian clinicians say severe influenza disproportionately affects elderly citizens, children under five, and individuals with chronic illnesses.

They recommend increased awareness campaigns during peak respiratory infection periods, particularly in densely populated urban centres.

Policy Implications for Nigeria

Public health stakeholders argue that Nigeria must integrate influenza planning into broader epidemic preparedness frameworks.

They emphasize the importance of budgetary allocations for laboratory diagnostics, antiviral stockpiles, and vaccination campaigns.

A senior health policy adviser in Abuja stated that Nigeria learned critical lessons during the COVID-19 pandemic.

He said proactive surveillance, transparent reporting, and international cooperation strengthen national health security.

Experts also urge collaboration between veterinary services, environmental agencies, and human health institutions under a One Health framework.

They warn that ignoring zoonotic surveillance could expose Nigeria to preventable outbreaks with socioeconomic consequences.

As WHO finalizes vaccine guidance for the northern hemisphere season, Nigerian authorities are reviewing implications for local immunization policies.

Health officials maintain that while influenza often receives limited public attention, its mortality burden demands sustained vigilance.

The updated recommendations, experts conclude, provide Nigeria an opportunity to reinforce surveillance, laboratory readiness, and public awareness before the next influenza cycle intensifies.